Trial intelligence / Profile preview

S-1 and Radiotherapy as Adjuvant Treatment for Rectal Cancer

NCT02277158Phase 1Unknown

Start
Nov 2014
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of tegafur in rectal cancer. Status: unknown.

02

Drugs

tegafur
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT02277158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02277158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call